Patents Assigned to Vascular Biogenetics Ltd.
  • Treatment methods using adenovirus
    Patent number: 11311583
    Abstract: The invention provides methods of reducing or decreasing a size of a tumor or eliminating a tumor by inhibiting, decreasing, or reducing neo-vascularization or angiogenesis in a tumor in a patient by administering an adenovirus comprising a nucleic acid construct comprising a FAS-chimera gene operably linked to an endothelial cell-specific promoter. Also provided is a homogeneous population of an adenovirus comprising a FAS-chimera gene operably linked to an endothelial cell-specific promoter and its uses thereof.
    Type: Grant
    Filed: July 23, 2018
    Date of Patent: April 26, 2022
    Assignee: Vascular Biogenetics Ltd.
    Inventors: Eyal Breitbart, Andrea Leubitz, Erez Feige, Richard Penson